Stockhub

BioLight Life Sciences Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 August 2022

  • curprev 06:5706:57, 26 August 2022 >Nick 1,220 bytes +1,220 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. The company's ophthalmic product offering and pipeline of product candidates include IOPtiMate, a laser-based surgical treatment for glaucoma; TeaRx, a point-of-care m..."
Retrieved from "https://stockhub.co/research/BioLight_Life_Sciences_Ltd."